MX1
Basic information
Region (hg38): 21:41420020-41470071
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 36 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 38 | 2 | 6 |
Variants in MX1
This is a list of pathogenic ClinVar variants found in the MX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-41432092-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
21-41432147-C-A | not specified | Uncertain significance (Aug 16, 2021) | ||
21-41432161-A-G | not specified | Uncertain significance (Dec 03, 2021) | ||
21-41432184-C-G | Benign (May 24, 2018) | |||
21-41435862-A-G | not specified | Uncertain significance (Apr 12, 2022) | ||
21-41435880-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
21-41435950-C-G | not specified | Uncertain significance (Sep 23, 2023) | ||
21-41435951-G-A | not specified | Uncertain significance (Aug 03, 2021) | ||
21-41436028-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
21-41437118-G-A | Benign (Jul 31, 2018) | |||
21-41439705-A-G | not specified | Uncertain significance (May 18, 2023) | ||
21-41439711-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
21-41439805-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
21-41441771-C-G | not specified | Uncertain significance (Sep 22, 2022) | ||
21-41441779-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
21-41441800-A-G | not specified | Uncertain significance (Apr 22, 2024) | ||
21-41441836-A-G | not specified | Uncertain significance (Feb 06, 2024) | ||
21-41441860-T-G | not specified | Uncertain significance (Jun 06, 2023) | ||
21-41441890-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
21-41441893-T-C | not specified | Uncertain significance (Jan 18, 2022) | ||
21-41443796-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
21-41443800-G-A | Likely benign (Mar 29, 2018) | |||
21-41443804-G-A | Benign (May 24, 2018) | |||
21-41443814-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
21-41443823-G-A | not specified | Uncertain significance (Sep 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MX1 | protein_coding | protein_coding | ENST00000398600 | 13 | 38911 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.42e-18 | 0.0181 | 125576 | 2 | 170 | 125748 | 0.000684 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.319 | 375 | 393 | 0.955 | 0.0000232 | 4379 |
Missense in Polyphen | 109 | 136.21 | 0.80024 | 1400 | ||
Synonymous | 0.297 | 152 | 157 | 0.970 | 0.0000100 | 1257 |
Loss of Function | 0.587 | 29 | 32.6 | 0.889 | 0.00000156 | 385 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00400 | 0.00393 |
Ashkenazi Jewish | 0.00109 | 0.00109 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000564 | 0.000563 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000261 | 0.000229 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Interferon-induced dynamin-like GTPase with antiviral activity against a wide range of RNA viruses and some DNA viruses. Its target viruses include negative-stranded RNA viruses and HBV through binding and inactivation of their ribonucleocapsid. May also antagonize reoviridae and asfarviridae replication. Inhibits thogoto virus (THOV) replication by preventing the nuclear import of viral nucleocapsids. Inhibits La Crosse virus (LACV) replication by sequestering viral nucleoprotein in perinuclear complexes, preventing genome amplification, budding, and egress. Inhibits influenza A virus (IAV) replication by decreasing or delaying NP synthesis and by blocking endocytic traffic of incoming virus particles. Enhances ER stress-mediated cell death after influenza virus infection. May regulate the calcium channel activity of TRPCs. {ECO:0000269|PubMed:11880649, ECO:0000269|PubMed:14687945, ECO:0000269|PubMed:14752052, ECO:0000269|PubMed:15047845, ECO:0000269|PubMed:15355513, ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:16202617, ECO:0000269|PubMed:16413306, ECO:0000269|PubMed:17374778, ECO:0000269|PubMed:18668195, ECO:0000269|PubMed:19109387, ECO:0000269|PubMed:21900240, ECO:0000269|PubMed:21992152}.;
- Pathway
- Influenza A - Homo sapiens (human);Measles - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);The human immune response to tuberculosis;Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.498
Intolerance Scores
- loftool
- 0.224
- rvis_EVS
- -0.39
- rvis_percentile_EVS
- 27.05
Haploinsufficiency Scores
- pHI
- 0.170
- hipred
- N
- hipred_score
- 0.298
- ghis
- 0.555
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.875
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mx2
- Phenotype
Gene ontology
- Biological process
- mitochondrial fission;dynamin family protein polymerization involved in mitochondrial fission;apoptotic process;defense response;signal transduction;response to virus;response to type I interferon;negative regulation of viral genome replication;innate immune response;defense response to virus;type I interferon signaling pathway;membrane fusion
- Cellular component
- nucleus;cytoplasm;endoplasmic reticulum membrane;cytosol;membrane;nuclear membrane;mitochondrial membrane;perinuclear region of cytoplasm
- Molecular function
- GTPase activity;protein binding;GTP binding;microtubule binding;identical protein binding